Sign In
Buy DVAX
$15.50
+0 (+0%)
At Close: May 08, 2026
Valneva Completes Phase 3 Trial Recruitment for its Inactivated COVID-19 Vaccine Candidate
01:15pm, Thursday, 03'rd Jun 2021
Saint- Herb lain (France ) , June 3 , 2021 –Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant
Why Dynavax Stock Is Rising Today
11:49am, Thursday, 27'th May 2021
The company signed a key deal to market its hepatitis B vaccine in Germany.
Dynavax, Bavarian Nordic Ink Distribution Pact For Hepatitis B Vaccine In Germany
08:47am, Thursday, 27'th May 2021
Dynavax Technologies Corporation (NASDAQ: DVAX) has entered into a commercialization agreement with Bavarian Nordic for the marketing and distribution of HEPLISAV B, the Hepatitis B vaccine in Germ
EMERYVILLE, Calif., May 27, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today announce
Dynavax to Present at the William Blair 41st Annual Growth Stock Conference
04:05pm, Wednesday, 19'th May 2021
EMERYVILLE, Calif., May 19, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today announced
Valneva to Participate in the World's First COVID-19 Vaccine Booster Trial in the UK
12:05pm, Wednesday, 19'th May 2021
Saint- Herb lain (France) , May 19 , 2 021 – Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significan
Dynavax: A Strong 2021 Plus Market Tailwinds Makes This Discounted Stock Attractive
07:23am, Thursday, 13'th May 2021
Dynavax stock is currently trading around $7.30, having peaked at $11 in early April. A potential buy opportunity.
Why Dynavax Technologies Stock Is Sinking Again Today
12:08pm, Tuesday, 11'th May 2021
The company announced the pricing of its senior convertible notes offering.
Dynavax Announces Pricing of $200 Million Convertible Senior Notes Offering
07:30am, Tuesday, 11'th May 2021
EMERYVILLE, Calif., May 11, 2021 /PRNewswire/ -- Dynavax Technologies Corporation ("Dynavax") (Nasdaq: DVAX) today announced the pricing of $200.0 million aggregate principal amount of 2.50% conve
Dynavax Technologies: An Emerging Covid19 Dynamo
03:03pm, Monday, 10'th May 2021
Dynavax Technologies: An Emerging Covid19 Dynamo
Why Dynavax Stock Is Nosediving Today
12:18pm, Monday, 10'th May 2021
The biotech announced a senior convertible notes offering.
DVAX Stock: Over 13% Decrease Intraday Explanation
10:35am, Monday, 10'th May 2021
The stock price of Dynavax Technologies Corporation (NASDAQ: DVAX) fell by over 13% during intraday trading. This is why it happened.
Dynavax Announces Proposed Private Offering of $200 Million of Convertible Senior Notes
07:10am, Monday, 10'th May 2021
EMERYVILLE, Calif., May 10, 2021 /PRNewswire/ -- Dynavax Technologies Corporation ("Dynavax") (Nasdaq: DVAX) today announced that it intends to offer, subject to market conditions and other factors
How Dynavax Demolished Expectations With Its Q1 Results
06:02am, Friday, 07'th May 2021
The company's hepatitis B vaccine wasn't its key growth driver.
Dynavax Technologies Corporation (DVAX) CEO Ryan Spencer on Q1 2021 Results - Earnings Call Transcript
11:40pm, Thursday, 06'th May 2021
Dynavax Technologies Corporation (DVAX) CEO Ryan Spencer on Q1 2021 Results - Earnings Call Transcript
